Orphan Europe has been developing, co-developing and distributing orphan drugs since 1990, well before the orphan drug legislation was introduced in Europe. Thanks to a complete dedication to and understanding of this market, Orphan Europe is experiencing a 20-30% annual growth in sales.
Today Orphan Europe maintains a good balance between in-house developed drugs, co-development and distribution agreements. It is a highly qualified organisation with expertise in medical, regulatory, marketing and distribution issues for orphan drugs, providing 10+ medicinal products to patients all over the world.
Orphan Europe cooperates with a number of well-established pharmaceutical and biotechnology companies as well as research institutes. These partnerships have involved co-development, clinical studies, regulatory applications, production, marketing and worldwide distribution.
Looking for a partner?
Are you a company working with orphan drugs? Do you need a co-development partner? Are you looking for expertise in developing your European regulatory dossier? Do you need access to the European or Middle East market?
Please contact our business development department at: